tiprankstipranks
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
US Market

Viridian Therapeutics (VRDN) Income Statement

Compare
1,371 Followers

Viridian Therapeutics Income Statement

Last quarter (Q4 2024), Viridian Therapeutics's total revenue was $72.00K, a decrease of 0.00% from the same quarter last year. In Q4, Viridian Therapeutics's net income was $-79.72M. See Viridian Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 302.00K$ 314.00K$ 1.77M$ 2.96M$ 1.05M
Gross Profit
$ 302.00K$ -1.01M$ 1.02M$ 2.34M$ -27.25M
Operating Expenses
$ 299.34M$ 254.76M$ 136.08M$ 82.69M$ 41.57M
Depreciation and Amortization
$ 540.00K$ 522.00K$ 755.00K$ 620.00K$ 539.00K
EBITDA
$ -266.36M$ -234.56M$ -128.63M$ -78.79M$ -109.67M
Operating Income
$ -299.04M$ -254.45M$ -134.30M$ -79.73M$ -110.38M
Other Income/Expenses
$ 29.09M$ 16.72M$ 4.43M$ 315.00K$ -335.00K
Pretax Income
$ -269.95M$ -237.73M$ -129.87M$ -79.41M$ -110.72M
Net Income
$ -269.95M$ -237.73M$ -125.44M$ -79.42M$ -110.98M
Per Share Metrics
Basic EPS
$ -3.98$ -5.31$ -3.91$ -6.66$ -31.20
Diluted EPS
$ -3.98$ -5.31$ -3.91$ -6.66$ -31.20
Weighted Average Shares Outstanding
67.89M 44.76M 32.09M 11.92M 3.56M
Weighted Average Shares Outstanding (Diluted)
67.89M 44.76M 32.09M 11.92M 3.56M
Currency in USD

Viridian Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis